Scientific studies on the use of stem cells for cardiac repair, were examined this morning during the opening session of the Winter Research Meeting of the Heart Failure Association of the European Society of Cardiology. Findings in experiments conducted with rodent engineered heart tissue (EHT) in Germany, indicate the great potential of pluripotent stem cells for use in cardiac repair. The meeting takes place in Garmisch-Partenkirchen from January 23 to 26. Over one hundred top cardiologists from all over Europe, Japan and the United States are attending the annual event.

New data which improves our understanding of the importance of diastolic heart failure will also be presented and discussed at the convention. Other topics on the agenda: cardiac remodelling and genetic pathways in cardiovascular development.

"The major goal for this meeting is to bring together the very best scientists from Europe and around the world working on basic and translational science in the field of heart failure ... in order to encourage intense and robust scientific exchanges and discussion relating to the latest data and advances" stated Prof Kenneth Dickstein, President of the Heart Failure Association of the European Society of Cardiology in his welcome address. "The active involvement of junior investigators is also encouraged" explained Prof Dickstein.

EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
The European Heart House
2035 Route des Colles
B.P. 179 - Les Templiers
FR-06903 Sophia Antipolis
escardio